A Double-Blind, Randomized Trial of High-Dose vs Standard-Dose Influenza Vaccine in Adult Solid-Organ Transplant Recipients | Zendy

Yoichiro Natori | Zendy; Mika Shiotsuka | Zendy; Jaclyn Slomovic | Zendy; Katja Höschler | Zendy; Victor H. Ferreira | Zendy; Peter D. Ashton | Zendy; Coleman Rotstein | Zendy; Les Lilly | Zendy; Jeffrey Schiff | Zendy; L.G. Singer | Zendy; Atul Humar | Zendy; Deepali Kumar | Zendy

Open Access

A Double-Blind, Randomized Trial of High-Dose vs Standard-Dose Influenza Vaccine in Adult Solid-Organ Transplant Recipients

Author(s) -

Yoichiro Natori,

Mika Shiotsuka,

Jaclyn Slomovic,

Katja Höschler,

Victor H. Ferreira,

Peter D. Ashton,

Coleman Rotstein,

Les Lilly,

Jeffrey Schiff,

L.G. Singer,

Atul Humar,

Deepali Kumar

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix1082

Subject(s) - medicine , seroconversion , immunogenicity , influenza vaccine , hemagglutination assay , population , immunology , confidence interval , vaccination , titer , antigen , antibody , environmental health

The annual standard-dose (SD) influenza vaccine has suboptimal immunogenicity in solid organ transplant recipients (SOTRs). Influenza vaccine that contains higher doses of antigens may lead to greater immunogenicity in this population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research